Search
Abcellera Biologics Inc
ABCLAdd to Watchlist
12.310USD
-0.340-2.69%
Close 09-22 16:00（ET）
3.76BMarket Cap
LossP/E TTM
After-hours 17:00 (ET)12.340USD+0.025+0.20%
After-hours 17:00 (ET)TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-2.69%
5 Days
+7.89%
1 Month
+8.75%
6 Months
+262.06%
Year to Date
+259.94%
1 Year
+154.87%
Key Figures
12.540Open
12.970High
693.36KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.23%Turnover Ratio
12.650Prev. Close
12.100Low
8.52MTurnover
LossP/E Static
4.20P/B
0.00%Div Yield TTM
-10.86%ROA
13.18052wk High
0.13Volume Ratio
-162.86MNet Profit
305.38MShares
-0.4793EPS TTM
1.12Beta
-14.68%ROE
2.74552wk Low
6.88%Amplitude
100.00%Gross Margin
3.76BMarket Cap
20.28Reward/Risk
5.47%Risk Rate
More news coming soon, stay tuned...
Abcellera Biologics Inc's Score
-0.04vs previous score
Forecast8.22
Financial Health6.85
Technical4.76
Valuation Dimensions9.16
Institutional Confidence3.00
Risk Assessment3.59
Media Coverage
Coverage Level
Very Low
Very High
Positive
Analyst Rating
Abcellera Biologics Inc Technical Analysis
Technical Indicators
Sell
Summary
Buy
Moving Average
Strong buy
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.18/-0.14
Revenue / Forecast
4.05M/7.78M
Abcellera Biologics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolABCL
Number of employees596
CountryCanada
Ownership
| Shareholders | Proportion |
|---|---|
| Thermopylae Holdings Ltd | 18.38% |
| Baker Bros. Advisors LP | 9.01% |
| Capital World Investors | 4.38% |
| Two Sigma Investments, LP | 3.52% |
| Shareholder Types | Proportion |
|---|---|
| Corporation | 18.39% |
| Hedge Fund | 15.77% |
| Investment Advisor | 11.92% |
| Research Firm | 4.81% |
Related Instruments
-1.64%
-0.01%
-0.05%
-1.88%
+1.01%
-2.99%
-1.01%
-0.85%
-3.12%
+0.90%
+0.26%
-1.77%
-1.20%
-2.00%
-1.99%
-0.26%
-0.25%
-0.74%
-1.86%
-0.35%Popular Instruments
51490.000
-361.000 (-0.70%)
30477.900
-223.300 (-0.73%)
7707.000
-53.700 (-0.69%)
14422.000
-217.000 (-1.48%)
66129.000
-893.000 (-1.33%)
6290.000
-55.800 (-0.88%)
92.490
+2.781 (+3.10%)
337.020
-2.730 (-0.80%)
225.510
-3.360 (-1.47%)
4286.240
-70.970 (-1.63%)
FAQs
What is the current price of Abcellera Biologics Inc (ABCL)?
The current price of Abcellera Biologics Inc (ABCL) is 12.65.
What is the symbol of Abcellera Biologics Inc?
The ticker symbol of Abcellera Biologics Inc is ABCL.
What is the 52-week high of Abcellera Biologics Inc?
The 52-week high of Abcellera Biologics Inc is 13.18.
What is the 52-week low of Abcellera Biologics Inc?
The 52-week low of Abcellera Biologics Inc is 2.75.
What is the market capitalization of Abcellera Biologics Inc?
The market capitalization of Abcellera Biologics Inc is 3.86B.
Is Abcellera Biologics Inc (ABCL) currently rated as Buy, Hold, or Sell?
According to analysts, Abcellera Biologics Inc (ABCL) has an overall rating of Buy, with a price target of 17.12.
What is the Earnings Per Share (EPS TTM) of Abcellera Biologics Inc (ABCL)?
The Earnings Per Share (EPS TTM) of Abcellera Biologics Inc (ABCL) is -0.48.